Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

PURPOSE: Metastatic response to induction therapy for high-risk neuroblastoma is a prognostic factor. In the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN) HR-NBL-1 protocol, only patients with metastatic complete response (CR) or partial response (PR) with ≤ three abnorm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Amoroso, Loredana, Erminio, Giovanni, Makin, Guy, Pearson, Andrew D. J., Brock, Penelope, Valteau-Couanet, Dominique, Castel, Victoria, Pasquet, Marlène, Laureys, Genevieve, Thomas, Caroline, Luksch, Roberto, Ladenstein, Ruth, Haupt, Riccardo, Garaventa, Alberto
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784636/
https://ncbi.nlm.nih.gov/pubmed/28324923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados